Rob Sambursky, MD, has 20 years of industry and clinical medical experience. He is one of the original founders of RPS Diagnostics and currently leads Lumos Diagnostics as its President and Chief Executive Officer. He has served as the acting Chief Medical Officer for either RPS Diagnostics or Lumos Diagnostics since 2008. In addition, Dr Sambursky is a member of the Lumos Diagnostics Board of Directors and PPK Solutions Board of Directors, and serves as the Executive Chairman for Visus Therapeutics, Inc. Dr Sambursky has a strong scientific and clinical background in medical sciences, ophthalmology, and infectious disease. He has authored numerous patents and scientific papers, conceived a novel point-of-care (POC) diagnostic test platform, served as the clinical and regulatory interface that led to multiple POC diagnostic tests obtaining international regulatory clearances as well as US FDA 510(k) clearances with CLIA waiver designations, and successfully commercialized multiple diagnostic tests in the US and abroad.
Dr Sambursky is a practicing board-certified ophthalmologist with fellowship training in refractive surgery and corneal external and infectious disease. He earned a BA in Biology from Brown University, an MA in Medical Sciences with concentrations in biochemistry and microbiology from Boston University, and an MD from Boston University School of Medicine. Dr Sambursky completed his medical internship at Harvard’s Mount Auburn Hospital and both his ophthalmology residency and cornea fellowship at Wills Eye Hospital in Philadelphia.